PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2020. Start Trial.
Date Value
November 18, 2026 1.399
November 17, 2026 1.440
November 16, 2026 1.523
November 13, 2026 1.619
November 12, 2026 1.619
November 11, 2026 1.708
November 10, 2026 1.57
November 09, 2026 1.883
November 06, 2026 2.134
November 05, 2026 1.975
November 04, 2026 2.188
November 03, 2026 2.109
November 02, 2026 2.072
October 30, 2026 2.272
October 29, 2026 2.435
October 28, 2026 2.406
October 27, 2026 2.291
October 26, 2026 2.264
October 23, 2026 2.274
October 22, 2026 2.391
October 21, 2026 2.397
October 20, 2026 2.397
October 19, 2026 2.310
October 16, 2026 2.304
October 15, 2026 2.411
Date Value
October 14, 2026 2.275
October 13, 2026 2.438
October 12, 2026 2.515
October 09, 2026 2.538
October 08, 2026 2.303
October 07, 2026 2.424
October 06, 2026 2.419
October 05, 2026 2.435
October 02, 2026 2.380
October 01, 2026 2.405
September 30, 2026 2.445
September 29, 2026 2.663
September 28, 2026 2.670
September 25, 2026 2.730
September 24, 2026 2.717
September 23, 2026 2.634
September 22, 2026 2.824
September 21, 2026 2.723
September 18, 2026 2.597
September 17, 2026 2.588
September 16, 2026 2.598
September 15, 2026 2.584
September 14, 2026 2.673
September 11, 2026 2.553
September 10, 2026 2.546

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
HealthEquity, Inc. 6.114
The Cigna Group 0.2634
Eli Lilly & Co. 14.50
Ontrak, Inc. --
BNB Plus Corp. 0.2398

PS Ratio Related Metrics